Definitive Contract HHSN272201200042C
Award Date 9/26/12
Potential Completion Date 10/20/12
Potential Value $647K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20170, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Lifesource Biomedical, LLC (DBA LSB Services), an Alaskan Native Corporation-owned firm registered as a minority-owned, small disadvantaged business. The $1,347,700.25 Definitive Contract was awarded by the Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) on September 26, 2012, with a completion date of October 20, 2012. This contract does not have a set-aside designation. Based on the contract...
- This is a $650,985.72 firm fixed-price definitive contract awarded by the National Heart Lung and Blood Institute, a component of the U.S. Department of Health and Human Services, to Lifesource Biomedical, LLC (doing business as LSB Services), an Alaskan Native Corporation-owned minority-owned and small disadvantaged business. The contract is for the provision of unspecified "other functions - non R & D, instruments and laboratory equipment" and was awarded on a sole-source basis...
- This federal contract award, valued at $53,343.02, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Lifesource Biomedical, LLC (LSB Services). The contract is for the provision of an ENVISION XCITE MULTILABEL READER, catalog number 2104-0020A, and does not have a set-aside designation. LSB Services is an Alaskan Native Corporation-owned, minority-owned, small disadvantaged business structured...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Lifesource Biomedical, LLC (LSB Services), an Alaskan Native Corporation-owned, minority-owned, and small disadvantaged business. The contract, with a ceiling value of $496,135.81, is for the procurement of a Leica TCS SP8 Flexible Supply Unit AOBS for the NIAID. The contract was awarded on a firm-fixed price basis with no...
- The National Heart, Lung, and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $487,521.57 sole-source 8(a) contract to Lifesource Biomedical, LLC (LSB Services) for laboratory equipment and supplies. The firm-fixed-price definitive contract has a performance period ending on January 3, 2014. LSB Services is an Alaskan Native Corporation-owned, minority-owned, small disadvantaged business registered as a for-profit limited liability company....
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is a component of the United States Department of Health and Human Services, to Lifesource Biomedical, LLC (doing business as LSB Services), a minority-owned small disadvantaged business. The contract, valued at $52,944.80, was a firm fixed-price purchase order for a WI-COM SENSUS software license. The contract had no set-aside designation and had an ultimate completion date of October 20, 2012....
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $398,623 firm-fixed-price definitive contract to Lifesource Biomedical, LLC (LSB Services) for laboratory equipment and supplies. LSB Services is an Alaskan Native Corporation-owned firm registered as a minority-owned, small disadvantaged business. The contract has an ultimate completion date of November 9, 2012 and did not utilize any set-aside designation....
- The U.S. Department of Health and Human Services National Heart Lung and Blood Institute awarded a $458,314.50 firm-fixed-price definitive contract to Lifesource Biomedical, LLC (doing business as LSB Services) for laboratory equipment and supplies. The contract is an 8(a) sole source award with a period of performance through January 31, 2014. LSB Services is an Alaskan Native Corporation-owned small disadvantaged business. The company has prior experience providing biomedical-related...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Lifesource Biomedical, LLC (LSB Services), an Alaskan Native Corporation-owned, minority-owned, and small disadvantaged business. The purpose of this $180,315.87 contract is to acquire a researcher to be located in the FDA's India office. The contract has no set-aside designation. Based on LSB Services' prior awards from the Centers for Disease Control and Prevention for anthrax supplies, this contract...
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Lifesource Biomedical, LLC (LSB Services), an Alaskan Native Corporation-owned, minority-owned, and small disadvantaged business. The contract, worth a ceiling value of $80,851.62, is for the provision of international laboratory supplies and logistics under an Indefinite Delivery Indefinite Quantity (IDIQ) vehicle....
This is a Fiscal Year 2012 8(a) contract award to Lifesource Biomedical, LLC (LSB Services), an Alaskan Native Corporation-owned firm registered as a minority-owned, small disadvantaged business. The $646,633.28 firm fixed-price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract is for the provision of unspecified biomedical or medical supplies, as evidenced by LSB Services' prior contract work with the Centers for Disease Control and Prevention. No set-aside designation was used for this award. The contract has a period of performance ending on October 20, 2012.
Generated 6/6/25, 9:55 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $646.6k | 9/26/12 |